- Report
- February 2019
- 300 Pages
Global
From €4095EUR$4,499USD£3,478GBP
- Report
- January 2024
- 263 Pages
Global
From €5301EUR$6,028USD£4,350GBP
- Directory
- May 2024
Global
- Report
- January 2024
- 36 Pages
Europe
€2685EUR$2,950USD£2,281GBP
- Report
- April 2023
- 35 Pages
China
From €4505EUR$4,950USD£3,827GBP
- Report
- August 2024
- 660 Pages
Brazil
From €3004EUR$3,300USD£2,551GBP
- Report
- October 2023
- 470 Pages
Global
From €2548EUR$2,800USD£2,165GBP
- Report
- September 2023
- 75 Pages
Global
From €3004EUR$3,300USD£2,551GBP
- Report
- June 2023
- 840 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- March 2023
- 300 Pages
Global
From €2548EUR$2,800USD£2,165GBP
- Report
- July 2022
- 111 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Report
- July 2022
- 600 Pages
Global
From €3004EUR$3,300USD£2,551GBP
- Report
- June 2022
- 1500 Pages
Global
From €3550EUR$3,900USD£3,015GBP
- Report
- May 2022
- 330 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Report
- May 2022
- 510 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Report
- April 2022
- 240 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Drug Pipelines
- March 2022
- 900 Pages
Global
From €8192EUR$9,000USD£6,958GBP
- Report
- February 2022
- 360 Pages
United States
From €3277EUR$3,600USD£2,783GBP
- Report
- December 2021
- 120 Pages
Global
From €3004EUR$3,300USD£2,551GBP
- Report
- November 2021
- 222 Pages
Global
From €2731EUR$3,000USD£2,319GBP

The Clinical Development market is a key component of the Drug Discovery process. It involves the testing of new drugs and treatments on human subjects in order to assess their safety and efficacy. Clinical Development typically involves a series of phases, beginning with pre-clinical trials and progressing through to Phase I, II, and III clinical trials. The results of these trials are used to determine whether a drug should be approved for use by regulatory authorities.
The Clinical Development market is highly competitive, with a range of companies offering services such as clinical trial design, data management, and regulatory consulting. These companies are often specialized in specific therapeutic areas, such as oncology, neurology, and cardiology. Examples of companies in the Clinical Development market include Parexel, ICON, and Syneos Health. Show Less Read more